Elevai Labs, Inc. Common Stock Cash Flow-to-Debt Ratio
Elevai Labs, Inc. Common Stock cash flow-to-debt ratio. Elevai Labs, Inc. Common Stock (ELAB) has a Cash Flow-to-Debt Ratio of -0.10x as of June 2026, meaning its operating cash flow of $-1.99 Million could theoretically repay 0% of its total liabilities ($19.83 Million) in one year. Check ELAB cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Elevai Labs, Inc. Common Stock (2020–2025)
Cash flow-to-debt ratio of Elevai Labs, Inc. Common Stock from 2020 to 2025. Historical debt coverage capacity for Elevai Labs, Inc. Common Stock across 6 annual periods. Also explore ELAB shareholders equity momentum to track the company's year-over-year net asset growth rate.
Elevai Labs, Inc. Common Stock Cash Flow-to-Debt Ratio by Year (2020–2025)
Elevai Labs, Inc. Common Stock cash flow-to-debt ratio by year from 2020 to 2025. Year-by-year debt coverage analysis for Elevai Labs, Inc. Common Stock. For the full cash flow conversion analysis, see ELAB cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.18x | $-5.93 Million | $5.03 Million | ▲ +49.8% |
| 2024 | -2.35x | $-5.49 Million | $2.33 Million | ▲ +29.7% |
| 2023 | -3.34x | $-4.56 Million | $1.36 Million | ▼ -60.4% |
| 2022 | -2.08x | $-1.59 Million | $760.87K | ▲ +32.0% |
| 2021 | -3.07x | $-660.93K | $215.62K | ▲ +42.7% |
| 2020 | -5.35x | $-217.16K | $40.61K | — |